Richard L. Gelfond, CEO of IMAX Corporation (NYSE: IMAX), has demonstrated a consistent pattern of selling activity in the company’s stock over recent years, with minimal offsetting purchases. Since 2024, Gelfond has executed 33 reported transactions, all involving IMAX shares, with total sales exceeding $25.8 million against buys of just $3.8 million. His most recent transactions include a sale of $4.86 million worth of shares on March 10, 2026, following a $6.51 million sale on March 7, 2026. These disposals align with a broader trend of periodic, high-value sell-offs, including a $2.71 million transaction in May 2025.
Notably, Gelfond’s buying activity has been limited to derivative transactions, such as the $3.81 million option exercise on March 10, 2026, which was immediately followed by the aforementioned sale. The majority of his transactions appear to be tied to scheduled events, including annual stock awards and tax-related dispositions, as evidenced by filings marked with codes "F" (payment of exercise price or tax liability) and "S" (open market sale). While his sales have been substantial, they are often accompanied by regulatory disclosures indicating prearranged trading plans, suggesting a structured approach to liquidity events rather than discretionary market timing. The absence of recent open-market purchases reinforces a clear divestment bias over the observed period.
AI-assisted summary